Less than two months after scoring what analysts deemed a "best-case" FDA approval for its cardiomyopathy drug Attruby, ...

Welcome to day 1 of the J.P. Morgan Healthcare Conference, the industry's most significant dealmaking event each year.  | For ...

At $132 per share, J&J paid a 39% premium on Friday’s closing price of Intra-Cellular, a New York City based biotech that ...

The biopharma industry’s deal-a-palooza, better known as the J.P. Morgan Healthcare Conference, has kicked off in San ...

Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...

What connects a broken windshield, a raccoon infestation and Peyronie’s disease? | What connects a broken windshield, a ...

Y-mAbs Therapeutics is parting ways with its chief commercial officer and putting a new hire in charge of the cancer drug ...

BioDuro, which was formed in 2005 in San Diego and China originally as a CRO, merged with contract manufacturer Formex in ...